Alzheimer's disease is a progressive brain disease that destroys cognitive function: memory, thinking, and reasoning. Eventually patients can no longer carry out even simple daily tasks. People with Alzheimer's experience signs and symptoms in varying degrees.Alzheimer's disease develops gradually. The nerve damage it causes first affects learning and memory.
Stage 3: Mild Cognitive Decline -- A professional can diagnose early-stage Alzheimer's in some individuals by stage 3. Friends and family will begin to notice deficiencies. Common problems include difficulty planning, remembering names of close friends and family, and reading with very little retention.
Stage 6: Severe Cognitive Decline -- At this stage, mental difficulties continue to worsen. Individuals at stage 6 will need help with the toilet, they often become suspicious of those who help them , and tend to wander from home and become lost.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Traumatic Brain Injury Linked to Cardiovascular Disease, Study FindsA study has found a surprising connection between traumatic brain injury (TBI) and cardiovascular disease (CVD). Individuals with TBI are at an elevated risk of unfavorable cardiovascular outcomes for an extended period following the initial incident. Regular monitoring and implementing strategies to mitigate cardiovascular disease risk are crucial for healthcare practitioners.
Source: Medscape - 🏆 386. / 55 Read more »
First-Ever CRISPR-Based Therapy Approved for Sickle Cell DiseaseU.S. patients with sickle cell disease now have a novel treatment option: the first-ever CRISPR-based therapy.for use in patients age 12 years and older. In addition to offering hope of relief for people with severe forms of the painful blood disorder, the treatment, called Casgevy, is the world’s first to genetically tweak cells using theAnother gene therapy for sickle cell disease, called Lyfgenia and developed by biotech company bluebird bio, based in Somerville, Mass., was also approved December 8. Getting a green light for the first CRISPR-based medicine is exciting, says David Altshuler, chief scientific officer at Boston-based Vertex Pharmaceuticals, which developed the drug in a joint venture with CRISPR Therapeutics, a company in Cambridge, Mass. But the fact that the drug fills an unmet need for underserved patients is “more compelling to me, personally, than the fact that it’s CRISPR.” , most of them Black or Latino, have sickle cell disease. It is caused by a genetic defect in hemoglobin, the oxygen-carrying protein in red blood cells
Source: ScienceNews - 🏆 286. / 63 Read more »
Stomach cancer symptoms and risk factors to know following Toby Keith's deathWhat to know about stomach cancer symptoms, risk factors and treatment options after the death of Toby Keith, who previously revealed he was undergoing treatment for the disease.
Source: CBSHealth - 🏆 480. / 51 Read more »